Lista de obras - Ilya Ulasov - Dominio Público Uruguay

A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model

artículo científico publicado en 2018

A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.

artículo científico publicado en 2009

A high-performance nanobio photocatalyst for targeted brain cancer therapy

artículo científico publicado en 2009

A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery

artículo científico publicado en 2012

A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.

artículo científico publicado en 2008

Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.

artículo científico publicado en 2012

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy

artículo científico publicado en 2017

Autophagy in glioma cells: An identity crisis with a clinical perspective.

artículo científico publicado en 2018

Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats

artículo científico publicado en 2008

CD46 represents a target for adenoviral gene therapy of malignant glioma.

artículo científico publicado en 2006

CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy

artículo científico publicado en 2016

Cancer stem cells: the final frontier for glioma virotherapy.

artículo científico publicado en 2011

Cathepsin B: A sellsword of cancer progression

scientific article published on 20 February 2019

Chemokines in tumor progression and metastasis

artículo científico publicado en 2013

Conditionally replicative adenoviral vectors for malignant glioma.

artículo científico publicado en 2006

Cytomegalovirus as an oncomodulatory agent in the progression of glioma.

artículo científico publicado en 2016

Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma

artículo científico publicado en 2014

Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer

artículo científico publicado en 2018

Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene

artículo científico publicado en 2015

Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression.

artículo científico publicado en 2017

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.

artículo científico publicado en 2013

KISS1 in breast cancer progression and autophagy

artículo científico publicado en 2019

KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro.

artículo científico publicado en 2017

Landscape of combination therapy trials in breast cancer brain metastasis

scientific article published on 22 February 2020

Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells

artículo científico publicado en 2008

MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo

artículo científico publicado en 2015

MULTIFUNCTIONAL NANO-BIO MATERIALS WITHIN CELLULAR MACHINERY ⬇️

artículo científico publicado el 1 de agosto de 2011

Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors.

artículo científico

MicroRNAs in brain metastases: big things come in small packages.

artículo científico publicado en 2012

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

artículo científico publicado en 2011

Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo

artículo científico publicado en 2008

Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.

artículo científico publicado en 2009

Oncolytic adenoviruses: A thorny path to glioma cure

artículo científico publicado en 2014

Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy.

artículo científico publicado en 2017

Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.

artículo científico publicado en 2009

TMZ regulates GBM stemness via MMP14-DLL4-Notch3 pathway

scientific article published on 01 October 2019

Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy

artículo científico publicado en 2015

Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX

artículo científico publicado en 2018

Targeted therapies for malignant glioma: progress and potential.

artículo científico publicado en 2009

The Challenge for Gene Therapy: Innate Immune Response to Adenoviruses ⬇️

artículo científico publicado el 1 de marzo de 2011

The emerging role of MMP14 in brain tumorigenesis and future therapeutics.

artículo científico

The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma

artículo científico publicado en 2010

Vector therapies for malignant glioma: shifting the clinical paradigm

scientific article published on 01 April 2008

WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer ⬇️

artículo científico publicado el 11 de enero de 2013

Lista de obras de Ilya Ulasov

A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model

A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.

A high-performance nanobio photocatalyst for targeted brain cancer therapy

A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery

A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.

Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy

Autophagy in glioma cells: An identity crisis with a clinical perspective.

Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats

CD46 represents a target for adenoviral gene therapy of malignant glioma.

CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy

Cancer stem cells: the final frontier for glioma virotherapy.

Cathepsin B: A sellsword of cancer progression

Chemokines in tumor progression and metastasis

Conditionally replicative adenoviral vectors for malignant glioma.

Cytomegalovirus as an oncomodulatory agent in the progression of glioma.

Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma

Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer

Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene

Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression.

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.

KISS1 in breast cancer progression and autophagy

KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro.

Landscape of combination therapy trials in breast cancer brain metastasis

Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells

MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo

MULTIFUNCTIONAL NANO-BIO MATERIALS WITHIN CELLULAR MACHINERY ⬇️

Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors.

MicroRNAs in brain metastases: big things come in small packages.

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo

Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.

Oncolytic adenoviruses: A thorny path to glioma cure

Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy.

Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.

TMZ regulates GBM stemness via MMP14-DLL4-Notch3 pathway

Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy

Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX

Targeted therapies for malignant glioma: progress and potential.

The Challenge for Gene Therapy: Innate Immune Response to Adenoviruses ⬇️

The emerging role of MMP14 in brain tumorigenesis and future therapeutics.

The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma

Vector therapies for malignant glioma: shifting the clinical paradigm

WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer ⬇️